Aqeilan, R. I., Hagan, J. P., de Bruin, A., Rawahneh, M., Salah, Z., Gaudio, E., . . . Croce, C. M. (2009). Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis. The Endocrine Society.
استشهاد بنمط شيكاغوAqeilan, Rami I., et al. Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis. The Endocrine Society, 2009.
MLA استشهادAqeilan, Rami I., et al. Targeted Ablation of the WW Domain-Containing Oxidoreductase Tumor Suppressor Leads to Impaired Steroidogenesis. The Endocrine Society, 2009.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.